Nurix Therapeutics
NRIX
#5019
Rank
โ‚ฌ1.55 B
Marketcap
15,03ย โ‚ฌ
Share price
-0.17%
Change (1 day)
74.97%
Change (1 year)

Revenue for Nurix Therapeutics (NRIX)

Revenue in 2026 (TTM): โ‚ฌ62.56 Million

According to Nurix Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ61.65 Million. In 2025 the company made a revenue of โ‚ฌ71.48 Million an increase over the revenue in the year 2024 that were of โ‚ฌ52.41 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nurix Therapeutics from 2020 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ62.56 M-12.48%
2025 โ‚ฌ71.48 M36.38%
2024 โ‚ฌ52.41 M-24.73%
2023 โ‚ฌ69.64 M93.4%
2022 โ‚ฌ36.01 M37.08%
2021 โ‚ฌ26.26 M81.32%
2020 โ‚ฌ14.48 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA